The product has been approved by the FDA for the treatment of type 1 diabetes. Beta Bionics (BBNX) hopes to develop the product for the type 2 diabetes market as well.

Other leading developers of insulin pumps include Tandem Diabetes Care (TNDM), Insulet ... Diginex and more Medtech test developer Anbio files for $9M US IPO Seeking Alpha’s Quant Rating ...